Loading chat...

MA S827

Bill

Status

Introduced

2/27/2025

Primary Sponsor

Bruce Tarr

Click for details

Origin

Senate

194th General Court

AI Summary

  • Regulates pharmacy benefits managers (PBMs) by establishing requirements for maximum allowable cost (MAC) lists, including that drugs must be FDA "A" or "AB" rated and available from at least two sources before being placed on such lists

  • Requires PBMs to reimburse pharmacies at or above the pharmacy's acquisition cost (with National Average Drug Acquisition Cost as a safe harbor) and prohibits setting lower MAC prices for non-affiliated pharmacies than for PBM-owned pharmacies

  • Mandates PBMs update MAC lists every 3 business days, provide lists to contracted pharmacies, and establish a 7-business-day appeals process for pharmacies to contest drug pricing with retroactive adjustments for valid appeals

  • Prohibits retroactive discounts (including Generic Effective Rate and Brand Effective Rate) and requires all discounts to be applied at the time claims are paid

  • Protects pharmacists from being penalized for disclosing cost-share information to patients or recommending more affordable alternative medications, and requires MassHealth managed care organizations to reimburse pharmacies at standard MassHealth rates

Legislative Description

To ensure access to prescription medications

Last Action

Accompanied a study order, see S2931

1/29/2026

Committee Referrals

Health Care Financing12/4/2025
Financial Services2/27/2025

Full Bill Text

No bill text available